We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+21.26%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$3.77B
AUM Growth
+$720M
(+24%)
Cap. Flow
+$280M
Cap. Flow
% of AUM
7.43%
Top 10 Holdings %
Top 10 Hldgs %
22.38%
Holding
294
New
116
Increased
45
Reduced
52
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$115M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$93.9M |
| 3 |
NXP Semiconductors
NXPI
|
+$57.1M |
| 4 |
Eli Lilly
LLY
|
+$51.1M |
| 5 |
Qorvo
QRVO
|
+$47.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$72.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$66.5M |
| 3 |
Amazon
AMZN
|
+$65.6M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$58.8M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$53.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.9% |
| 2 | Technology | 32.83% |
| 3 | Communication Services | 8.98% |
| 4 | Financials | 3.92% |
| 5 | Consumer Discretionary | 3.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JNPR
251
DELISTED
Juniper Networks
JNPR
| – | – |
-475,278
| Closed | -$10.2M |
|
252
Keysight
KEYS
$57.6B
| – | – |
-170,689
| Closed | -$16.9M |
|
|
LPRO
253
DELISTED
Open Lending Corp
LPRO
| – | – |
-363,797
| Closed | -$9.28M |
|
|
254
Microchip Technology
MCHP
$40.5B
| – | – |
-1,413,308
| Closed | -$72.6M |
|
255
McKesson
MCK
$102B
| – | – |
-64,755
| Closed | -$9.64M |
|
256
Molina Healthcare
MOH
$10B
| – | – |
-80,281
| Closed | -$14.7M |
|
257
Merck
MRK
$317B
| – | – |
-203,456
| Closed | -$16.1M |
|
258
Nu Skin
NUS
$253M
| – | – |
-88,581
| Closed | -$4.44M |
|
259
PagSeguro Digital
PAGS
$2.62B
| – | – |
-215,903
| Closed | -$8.14M |
|
260
Pliant Therapeutics
PLRX
$65M
| – | – |
-152,000
| Closed | -$3.44M |
|
261
Prelude Therapeutics
PRLD
$372M
| – | – |
-179,361
| Closed | -$5.4M |
|
262
Prothena Corp
PRTA
$449M
| – | – |
-177,084
| Closed | -$1.77M |
|
|
P
263
Everpure Inc
P
$29B
| – | – |
-136,529
| Closed | -$2.1M |
|
264
QuidelOrtho
QDEL
$1.12B
| – | – |
-9,645
| Closed | -$2.12M |
|
|
RAPT
265
DELISTED
RAPT Therapeutics
RAPT
| – | – |
-8,413
| Closed | -$2.17M |
|
266
Surgery Partners
SGRY
$1.95B
| – | – |
-144,837
| Closed | -$3.17M |
|
267
Silicon Laboratories
SLAB
$7.21B
| – | – |
-64,581
| Closed | -$6.32M |
|
268
Snap
SNAP
$8.81B
| – | – |
-1,459,062
| Closed | -$38.1M |
|
269
TD Synnex
SNX
$20.7B
| – | – |
-220,128
| Closed | -$15.4M |
|
270
Spotify
SPOT
$97.7B
| – | – |
-57,048
| Closed | -$13.8M |
|
271
Skyworks Solutions
SWKS
$10.1B
| – | – |
-155,478
| Closed | -$22.6M |
|
272
Stryker
SYK
$129B
| – | – |
-172,050
| Closed | -$35.9M |
|
273
Teradyne
TER
$60.2B
| – | – |
-303,605
| Closed | -$24.1M |
|
274
Wolfspeed
WOLF
$1.44B
| – | – |
-114,780
| Closed | -$7.32M |
|
275
Zoetis
ZTS
$32.4B
| – | – |
-59,057
| Closed | -$9.77M |
|
Similar funds
TCIIS
UIM
VAI
KK
Woodline Partners's Q4 2020 Portfolio in Review
As of Q4 2020, Woodline Partners held 294 positions worth $3.77B, up 24% from $3.05B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Woodline Partners deployed $280M of net new capital in Q4 2020, opening 116 new positions and adding to 45 existing holdings. Its largest new stake was Amgen: 500,520 shares worth $115M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 45% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $58.8M trimmed.
- Woodline Partners's largest Q4 2020 buy was Amgen: 500,520 shares worth $115M.
- Woodline Partners added most to Eli Lilly in Q4 2020, an estimated $51.1M increase.
- Woodline Partners's biggest Q4 2020 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $58.8M.
- Woodline Partners fully exited Microchip Technology in Q4 2020, selling an estimated $72.6M.
- Woodline Partners's ten largest holdings make up 22% of its $3.77B portfolio in Q4 2020.
- Woodline Partners opened 116 new positions and closed 77 in Q4 2020.
- Woodline Partners's portfolio value rose 24% quarter-over-quarter to $3.77B.
Based on Woodline Partners's 13F filing for Q4 2020, filed 16 Feb 2021.